Sally Mahmoud Shalaby

Prof. Sally Mahmoud Shalaby

Zagazig University, Zagazig, Egypt
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2013 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
AEAmal S. El-Shal
Amal S. El-Shal
SSSally Mahmoud Shalaby
Sally Mahmoud Shalaby
NANader M. Aly
Nader M. Aly
NRNearmeen M. Rashad
Nearmeen M. Rashad
AAAhmed M. Abdelaziz
Ahmed M. Abdelaziz

1 June 2014 in Cytotherapy
Verified
Journal Article
Closed access
SSSally Mahmoud Shalaby
Sally Mahmoud Shalaby
AEAmal S. El-Shal
Amal S. El-Shal
SASomia H. Abd-Allah
Somia H. Abd-Allah
ASAssmaa O. Selim
Assmaa O. Selim
SSSally A. Selim
Sally A. Selim
SAShymaa Abdelazim
Shymaa Abdelazim

27 June 2016 in IUBMB Life
Verified
Journal Article
Open access
PDF file
SSSally Mahmoud Shalaby
Sally Mahmoud Shalaby
AEAmal S. El-Shal
Amal S. El-Shal
ASAmira Shoukry
Amira Shoukry
MKMohamad H. Khedr
Mohamad H. Khedr
NANader Abdelraheim
Nader Abdelraheim
In clinical practice, there is still a need for novel biomarkers, which can reliably rule in or rule out acute coronary syndrome (ACS) immediately on admission. This is of particular interest in patients with unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI) in whom diagnostic uncertainty is high. The aim of the present study is to evaluate the potential role of miRNA-499 and miRNA-210 as novel molecular biomarkers for early diagnosis of UA and NSTEMI suspected patients presented at the emergency unit. A total of 110 patients presenting to the intensive care unit (ICU) within 24 h of onset of chest pain suggestive of ACS were enrolled in the study. They included 37 UA, 48 NSTEMI and 25 noncardiac chest pain (NCCP) patients. Immediately at enrollment, blood samples were taken for estimation of serum miRNA-499 and miRNA-210 expression levels by real time PCR. miRNA-499 and miRNA-210 expression levels were significantly increased in UA and NSTEMI patients compared with NCCP patients (P < 0.001). Receiver operating characteristic (ROC) curve analysis revealed that the area under curve (AUC) of miR-499 for the diagnosis of UA and NSTEMI was 0.98 and 0.97, respectively; while the AUC of miRNA-210 was 0.84 and 0.90, respectively. The important finding of our study was that the AUC of miRNA-499 for the diagnosis of ACS patients with symptoms onset <3 h was 0.89, while the AUC of miRNA-210 was 0.86. Interestingly, combining miRNA-499 and miRNA-210 significantly improved the diagnostic value by increasing the AUC to 0.96, P < 0.001. In conclusion, serum miRNA-499 and miRNA-210 are associated with UA and NSTEMI and with those presenting within 3 h of symptom onset. Both miRNAs might be potentially novel biomarkers for accelerating the diagnosis of ACS patients in emergency unit. © 2016 IUBMB Life, 68(8):673–682, 2016

1 May 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
AEAmal S. El-Shal
Amal S. El-Shal
SSSally Mahmoud Shalaby
Sally Mahmoud Shalaby
SASafwat E. Abouhashem
Safwat E. Abouhashem
EEEman H. Abd Elbary
Eman H. Abd Elbary
SASamir Azazy
Samir Azazy
WSWalaa Sarhan
Walaa Sarhan

12 January 2016 in IUBMB Life
Verified
Journal Article
Closed access
PDF file
SSSally Mahmoud Shalaby
Sally Mahmoud Shalaby
Norhan SabbahNorhan Sabbah
Norhan Sabbah
TSTaisir Saber
Taisir Saber
RHReda A. Abdel Hamid
Reda A. Abdel Hamid

1 July 2014 in Gene
Verified
Journal Article
Closed access
YHYousri M. Hussein
Yousri M. Hussein
SSSally Mahmoud Shalaby
Sally Mahmoud Shalaby
ANAmani Nassar
Amani Nassar
SASaad S. Alzahrani
Saad S. Alzahrani
AAAyman S. Alharbi
Ayman S. Alharbi
MNMaha Nouh
Maha Nouh